B. Barin

发表

Reduction of HIV Persistence Following Transplantation in HIV‐Infected Kidney Transplant Recipients

H. Hatano, P. Stock, M. Busch, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus–coinfected recipients versus human immunodeficiency virus–infected recipients without hepatitis C virus: Results from the national institutes of health multi‐site study

K. Olthoff, P. Stock, B. Murphy, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Malignancy in the HIV-infected patients undergoing liver and kidney transplantation

P. Stock, N. Nissen, B. Barin, 2012, Current opinion in oncology.

Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients

E. Schiff, K. Reddy, N. Terrault, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Vitamin D status of human immunodeficiency virus–positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi‐site study

A. Branch, T. Schiano, P. Stock, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.

S. Kochhar, J. Excler, P. Fast, 2009, AIDS research and human retroviruses.

Cyprus Women's Health Research (COHERE) initiative

B. Taneri, H. Naci, K. Zondervan, 2019 .

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

D. Stablein, L. Ferrell, K. Olthoff, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Surgical Complications in 275 Human Immunodeficiency Virus (HIV) Infected Liver and/or Kidney Transplant Recipients

K. Olthoff, P. Stock, J. Fung, 2012 .

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.

P. Kaleebu, A. McMichael, S. Wakasiaka, 2008, Vaccine.

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.

S. McCormack, A. McMichael, J. Weber, 2008, Vaccine.

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons

P. Stock, M. Sulkowski, A. Balagopal, 2015, PloS one.

Hemophilia Liver Transplantation Observational Study

D. Stablein, P. Stock, J. Fung, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver transplant outcomes in HIV(+) haemophilic men

D. Stablein, P. Stock, M. Ragni, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

THE COMPARISON OF CONSTITUENTS OF ESSENTIAL OILS OF ZHUMERIA MAJDAE RECH. F. & WENDELBO AT FLOWERING STAGES IN VARIOUS PARTS OF HORMOZGAN PROVINCE

A. Moradshahi, B. Barin, M. Barazandeh, 2007 .

Acquired hypogammaglobulinemia in HIV‐positive subjects after liver transplantation

D. Pitrak, K. Gregg, B. Barin, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

SOME PHYSIOLOGICAL RESPONSES OF CANOLA (BRASSICA NAPUS L.) TO WATER DEFICIT STRESS UN-DER LABORATORY CONDITIONS

A. Moradshahi, B. Barin, B. Andari, 2004 .

HIV‐Infected Liver and Kidney Transplant Recipients: 1‐ and 3‐Year Outcomes

D. Stablein, L. Benet, J. McCune, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.

K. Olthoff, P. Stock, J. Fung, 2012, Surgery.

Hepatitis E infection in HIV‐infected liver and kidney transplant candidates

N. Terrault, K. Sherman, M. T. Shata, 2014, Journal of viral hepatitis.

Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.

Todd M. Allen, R. Striker, P. Stock, 2013, Virology.

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.

Michael M Schwartz, J. Hennessey, D. Tribble, 2021, Vaccine.

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya

D. Bangsberg, O. Anzala, J. Haberer, 2014, AIDS and Behavior.

Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity

B. Taneri, N. Rahmioglu, T. Karaderi, 2020, Frontiers in Immunology.

Outcomes of kidney transplantation in HIV-infected recipients.

D. Stablein, G. Lyon, J. Melancon, 2010, The New England journal of medicine.

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.

G. Pantaleo, A. McMichael, W. Jaoko, 2007, Vaccine.

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults

W. Jaoko, O. Anzala, T. Hanke, 2016, Molecular therapy. Methods & clinical development.

Efficient Killing of Infected Cells, Production of Soluble Antiviral Factors T Cells in African Adults

W. Jaoko, O. Anzala, T. Hanke, 2022 .

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

J. Excler, P. Fast, P. Hayes, 2012, PloS one.

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls

K. Olthoff, P. Stock, W. Hardy, 2015, AIDS.

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

D. Stablein, P. Stock, J. Fung, 2010, Gastroenterology.

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya

O. Anzala, G. Omosa-Manyonyi, P. Fast, 2014, PloS one.

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers

D. Bangsberg, O. Anzala, J. Haberer, 2012, PloS one.

Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

A. Kamali, D. Bangsberg, J. Haberer, 2013, PloS one.

Cyprus Women’s Health Research (COHERE) initiative: determining the relative burden of women’s health conditions and related co-morbidities in an Eastern Mediterranean population

B. Taneri, H. Naci, K. Zondervan, 2019, BMC Women's Health.

Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial

K. Neuzil, W. A. Brooks, K. Zaman, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial

J. Bresee, K. Neuzil, K. Nahar, 2016, The Lancet. Global health.

ALLELOPATHIC EFFECTCTS OF ESSENTIAL OILS OF ZHUMERIA MAJDAE ON WHEAT (TRITICUM AESTIVUM) AND TOMATTO (LYCOPERSICON ESCULENTUM)

Rezaei Mohammad Bagher, A. Moradshahi, B. Barin, 2006 .

Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study

Özge Uluçkan, F. Selcuk, Ender Volkan, 2022, The Lancet Microbe.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

G. Omosa-Manyonyi, E. Chomba, J. Mpendo, 2015, PloS one.

Best Single Time Point Correlations With AUC for Cyclosporine and Tacrolimus in HIV-Infected Kidney and Liver Transplant Recipients

L. Benet, P. Stock, L. Frassetto, 2014, Transplantation.

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens

B. Gazzard, E. Karita, O. Anzala, 2016, The Journal of infectious diseases.

Activity on the multi-stranded Central Branch of the North Anatolian Fault along the southern shelf of the Marmara Sea, Turkey

M. Cormier, G. Çifçi, M. Steckler, 2014 .

Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots.

A. Başak, M. Uğurlucan, C. Conkbayir, 2017, The heart surgery forum.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Philip R. Johnson, S. Kochhar, J. van Lunzen, 2008, AIDS research and human retroviruses.

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.

Philip R. Johnson, P. Kaleebu, L. Bekker, 2010, AIDS research and human retroviruses.

Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV‐1 infected liver and kidney transplant recipients

U. Christians, L. Benet, P. Stock, 2013, Biopharmaceutics & drug disposition.

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

P. Kaleebu, S. Kochhar, J. van Lunzen, 2012, Human vaccines & immunotherapeutics.

Joint Investigation of 2-Month Post-diagnosis IgG Antibody Levels and Psychological Measures for Assessing Longer Term Multi-Faceted Recovery Among COVID-19 Cases in Northern Cyprus

T. Karaderi, H. Çakal, B. Barin, 2020, Frontiers in Public Health.

Outcomes of kidney transplantation in HIV-infected recipients.

D. Stablein, G. Lyon, J. Melancon, 2010, The New England journal of medicine.

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.

S. Kochhar, J. Excler, P. Fast, 2009, AIDS research and human retroviruses.